There are 2934 resources available
1804 - Immunological differences between immune-rich estrogen receptor-positive and -negative breast cancers
Presenter: Tess O'Meara
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
5826 - Impact of abstention of diagnostic biopsy in sarcoma
Presenter: Armelle Dufresne
Session: Poster Discussion – Sarcoma
Resources:
Abstract
4087 - EURO-B.O.S.S.: Outcome in rare non-osteosarcoma bone sarcoma
Presenter: Peter Reichardt
Session: Poster Discussion – Sarcoma
Resources:
Abstract
1363 - Trabectedin with concurrent low-dose of radiation therapy for metastatic soft tissue sarcomas: A phase II trial of Spanish, French and Italian sarcoma groups
Presenter: Javier Martin Broto
Session: Poster Discussion – Sarcoma
Resources:
Abstract
3627 - Complementary Medicine (CM) Use in Phase III Clinical Trials (P3T) Conducted by the Canadian Cancer Trials Group (CCTG)
Presenter: John Wells
Session: Poster Discussion – Supportive and palliative care
Resources:
Abstract
1399 - Phase 1 combination dose-finding/phase 2 expansion cohorts of lenvatinib + etoposide + ifosfamide in patients (pts) aged 2 to _25 years with relapsed/refractory (r/r) osteosarcoma
Presenter: Nathalie Gaspar
Session: Poster Discussion – Sarcoma
Resources:
Abstract
1884 - A Phase II Study of Pazopanib as Front-Line Therapy in Patients with Non-resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
Presenter: Angela Hirbe
Session: Poster Discussion – Sarcoma
Resources:
Abstract
3492 - Immune classification of soft tissue sarcoma predicts clinical outcome
Presenter: Florent Petitprez
Session: Poster Discussion – Sarcoma
Resources:
Abstract
3452 - Unravelling omics landscape and targeting oncogenic pathways in undifferentiated pleomorphic sarcomas (UPS)
Presenter: Maud Toulmonde
Session: Poster Discussion – Sarcoma
Resources:
Abstract
2413 - Implementation of PRO-CTCAE in phase I clinical trials identifies under reporting of adverse events
Presenter: Zachary Veitch
Session: Poster Discussion – Supportive and palliative care
Resources:
Abstract